Current Issues in the Surgical Management of Lung Cancer Jonathan Ferguson.

Slides:



Advertisements
Similar presentations
Thoracic Surgery Innovations
Advertisements

FACET - European Journal of Cancer Care March 2006 slides available at: Stereotactic radiosurgery Gordon, K. 1.
LUNG CANCER LUNG CANCER Lung Cancer  What Is Lung Cancer?  Lung Cancer is a disease caused by the rapid growth and division of cells that make up the.
Treatment.
Tissue Diagnosis and Staging for SBRT 2012 Lung Cancer Summit – Focus on Thoracic Surgery: Lung Cancer Kazuhiro Yasufuku Director, Interventional Thoracic.
Evidence for adjuvant radiation therapy benefiting breast cancer patients with 1 to 3 positive lymph nodes treated with a modified radical mastectomy and.
Bristol Thoracic Surgery Unit Update What we are doing well High resection rate.
Oncologic Results of Laparoscopic Versus Conventional Open Surgery for Stage II or III Left-Sided Colon Cancers A Randomized Controlled Trial A randomized.
North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.
“ Handle with Care” A GP guide to cancer care for elderly patients.
March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
September 5 th – 8 th 2013 Nottingham Conference Centre, United Kingdom
S Strong 1,2, NS Blencowe 1,2,T Fox 1, C Reid 3, T Crosby 4, H.Ford 5, J M Blazeby 1,2 1 School of Social and Community Medicine, Canynge Hall, University.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
Managing the patients experience of radical surgery with HIPEC for stage 4 colorectal disease Jackie Rodger Lead Colorectal Nurse Specialist Carol Baird.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Upper gastrointestinal cancers
The role of surgery in the management of mesothelioma Mr Martyn Carr Consultant Thoracic Surgeon Liverpool Heart and Chest Hospital.
Breast Cancer Surgery Challenging Preconceptions Hamish Brown Consultant Breast and General Surgeon Sandwell and West Birmingham Hospitals NHS Trust
Lars Påhlman Dept. Surgery, Colorectal unit, University Hospital, Uppsala, Sweden How to handle peritoneal carcinomatosis found at laparotomy.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
SURGEONS ROLE AND INVOLVEMENT IN SBRT PROGRAM Stephen R. Hazelrigg, M.D. Professor and Chair, Cardiothoracic Surgery Southern Illinois University, School.
Dr A.J.France, Ninewells Hospital, Dundee Lung cancer treatment 2010 © A.J.France 2010.
Metastasis Steps to metastases:
SURGERY FOR NSCLC GREG CHRISTODOULIDES MD, FACS, FCCP, FESTS
Resection For Lung Metastases M62 Coloproctology Course.
The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
JCUH NICE MSCC Guidelines Compliance audit Ruth Mhlanga Senior Specialist Physiotherapist Oncology and Haematology.
Chemotherapy Audit  Audit of patients who died within three months of their last dose of chemotherapy at Airedale General Hospital  The records of 50.
Surgery for lung cancer – a review
What Is Lung Cancer? Lung cancer is the uncontrolled growth of abnormal cells in the lung. Normal lung tissue is made up of cells that are programmed.
SCTS EDUCATION VATS lobectomy consultant mentoring Leads: Tom Routledge, Mike Shackcloth.
Approaching early stage disease
Understanding Patient Impact and Perspective MOQC, MiBOQI, and Pathways Tri-annual Meeting 1/22/2016 Jackie Rau, MHSA, CQI Project Lead Collaborative Quality.
Introduction to Tumor Board
Mesothelioma Nasty form of cancer Attributed to inhalation of asbestos fibers People who worked with or near asbestos typically at most risk.
The role of the Advanced Practitioner in the successful implementation and delivery of Image Guided Brachytherapy (IGBT): Katie Bradshaw Cambridge University.
Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly: A Population-Based Study in Ontario, Canada JOURNAL OF CLINICAL ONCOLOGY, VOLUME 30.
LEEDS TEACHING HOSPITALS NHS TRUST Division of Diagnostic and Therapeutic Services.
MACMILLAN AFTERCARE REHABILITATION TEAM (MARS) Anne Hope Head and Neck CNS.
Treatment of Stage I and II Non-small Cell Lung Cancer
Multi-station N2 Ca Lung
Palliative Care: Emergency Room Interaction
Non-melanoma skin cancer reconstruction of the head and neck region at Northampton General Hospital: a case series. Iqbal U1, Kapasi F2 Ameerally P3 1.
Bronchial Carcinoma Part 2
Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative.
Developments in colorectal surgery
Prognosis of younger patients in non-small cell lung cancer
Current and future research topics
Dr Jessica Jenkins Consultant Oncologist
NHS England Service Specification for Thoracic Surgery (Adult)
Pathway for patients with suspected Upper GI (OG) Cancer
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Neuro Oncology Therapy Update
Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Oncology Market Forecast
Liverpool Heart and Chest Hospital
Volume 383, Issue 9935, Pages (June 2014)
Surgical Treatment of Metachronous Second Primary Lung Cancer
What’s new in stage III lung cancer?
The role of simultaneous resection of synchronous liver metastasis and primary colorectal cancer Samuel Lo Department of Surgery.
Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R
Mark K Ferguson, MD, Amy G Lehman, BA  The Annals of Thoracic Surgery 
Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD 
Early and locally advanced breast cancer
Thoracic Surgery Survey on Lung Cancer Management
General principles of surgical oncology
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Presentation transcript:

Current Issues in the Surgical Management of Lung Cancer Jonathan Ferguson

Areas for Discussion Access to VATS Lobectomy The N2 debate Surgical cover of MDTs Concentrating expertise Tracheal resection Pancoast tumours Spinal Resection Working with SBRT

VATS Lobectomy More centres starting Still a small proportion of all resections +++ interest nationally in expanding access Less post op pain Potentially shorter post op stay Already being successfully performed by Mr Stamenkovic at the Freeman

The N2 Debate Do we operate on patients with N0 N1 disease only? N0 N1 and non bulky N2? N0 N1 and single station N2? Adjuvant or Neo-adjuvant therapy for N2? The debate continues For discussion at another time

Surgical Cover of MDTs – No Easy Solution The problems – Largest volume cancer – Surgery for only 10 – 15% of patients – Ratio of patients to surgeons is very high – Individual surgeons covering many hospitals – Surgeons enjoy theatre more than the MDT room!!!!! In contrast – Breast Cancer – Large volume – Simple pathway – Vast majority of tumours are removed – Breast surgeons in every hospital – Ratio of patients to Surgeons is low

Concentrating Surgical Expertise? Tracheal / Carinal resection, Spinal resection & Pancoast tumours No UK surgeon sees large numbers of these. The more a surgical team does the better it gets! Some large US centres provide this low volume, technically difficult surgery to large areas of population. Should the UK identify 2 or 3 centres for each of these problems?

Working Along with SBRT Main part of presentation Some surgeons worry that radiotherapy will reduce the number of cancer resections Some surgeons worry that SBRT is not as good as surgery This presentation will try to explain how informed patient choice is more important than cure!

The Surgeons’ View of SBRT An insight into the surgical mind Not evidence based Aims – To provoke discussion – The history of surgical reaction to new technology – Clarify motivation – Comparisons from the past – The role of a SBRT v Surgery trial

New Treatments for Old Diseases The Surgeon has a new toy – e.g. Laparoscopy The Physician has a new toy – e.g. Vascular stents

The New Toy Laparoscopy – the last few decades  Distrust  Enthusiasm from a few  Enthusiasm from many  Patient benefit  New challenge  Inappropriate application  Finally we have appropriate and beneficial equipoise

The New Toy in the Playground Others own the toy – New method CLEARLY BETTER than surgery for many patients Cerebral aneurysms and renal stones Change in surgical practice Little to argue about

The New Toy in the Playground Others own the toy – New method slightly better, as good or nearly as good as surgery for many patients Coronary Stents Peripheral Vascular stents – Threat to surgical practice – Much to argue about...

Much to argue about... Factors that fuel arguments – The narrower the gap in efficacy the bigger the debate and the bigger the trials needed – Moving goalposts – “The new stent is better” – How much of surgical practice is under threat.

Surgical Evolution “What will WE do if the oncologists cure cancer?” – a UK thoracic surgeon

Surgical Evolution “What will WE do if the oncologists cure cancer?” – CELEBRATE – Facilitate – Retrain Patient focused approach This is obvious and without controversy This needs to be said!

Facilitation Surgeons should be willing to provide surgical staging [e.g. mediastinoscopy] for patients who have chosen SBRT

Patient Choice SBRT does not need to be as good as surgery to have a valid role – As long as the patient understands the risks and benefits of each treatment then it is up to the patient to choose – NOT THE DOCTOR OR SURGEON – Patient focused approach – This is obvious and without controversy – This needs to be said!

Lessons from the past - Mesothelioma Long debate over many years concerning the role of extrapleural pneumonectomy in mesothelioma Divided opinion Patient anxiety

SBRT vs Surgery Trials Should happen Now Timely fashion Embraced by surgeons Physicians, surgeons and patients need to know how good it is.

The Areas for Debate - Summary Further access to VATS Lobectomy The N2 debate Surgical cover of MDTs Concentrating of expertise Tracheal resection Pancoast tumours Spinal Resection Working with SBRT

Questions